IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,831 | -4.8% | 6,000 | 0.0% | 0.00% | – |
| Q2 2023 | $6,125 | +1.9% | 6,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,012 | -8.1% | 6,000 | 0.0% | 0.00% | – |
| Q4 2022 | $6,544 | +9.1% | 6,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 35,225,000 | $39,760,000 | 1.94% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,079,000 | $4,662,000 | 0.54% |
| AQR Arbitrage LLC | 11,500,000 | $13,038,000 | 0.47% |
| Context Capital Management, LLC | 3,934 | $4,460,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,938,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,748,000 | 0.06% |
| LINDEN ADVISORS LP | 6,201,000 | $7,007,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 14,500,000 | $16,439,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $77,681,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,976,000 | $9,002,000 | 0.02% |